Abbott India Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals

Current Price Action and Market Context

As of 10 June 2026, Abbott India’s stock closed at ₹26,145.70, marking a 1.37% increase from the previous close of ₹25,792.95. The intraday range spanned from ₹25,601.35 to ₹26,230.00, indicating moderate volatility within the session. The stock remains significantly below its 52-week high of ₹35,921.55, while hovering just above its 52-week low of ₹25,164.00, underscoring a broad trading range that has challenged investors over the past year.

Technical Trend Evolution: From Bearish to Mildly Bearish

MarketsMOJO’s technical assessment reveals a subtle shift in Abbott India’s trend from outright bearish to mildly bearish. This transition suggests that while downward pressures persist, there are emerging signs of potential stabilisation or limited recovery. The daily moving averages continue to signal bearish momentum, with the stock trading below key averages, indicating that short-term selling pressure remains intact.

MACD and Momentum Oscillators

The Moving Average Convergence Divergence (MACD) indicator presents a mixed picture. On a weekly basis, the MACD is mildly bullish, hinting at a nascent positive momentum that could support a short-term price rebound. However, the monthly MACD remains mildly bearish, reflecting longer-term caution and the possibility of sustained downward pressure. This divergence between weekly and monthly MACD readings highlights the stock’s current technical uncertainty.

RSI and Bollinger Bands Analysis

The Relative Strength Index (RSI) offers no definitive signal on either the weekly or monthly charts, suggesting that the stock is neither overbought nor oversold at present. This neutral RSI reading aligns with the observed sideways price action. Conversely, Bollinger Bands indicate a mildly bearish stance on the weekly timeframe and a more pronounced bearish signal on the monthly scale. The stock price’s proximity to the lower band on the monthly chart suggests increased downside risk if selling intensifies.

KST and Dow Theory Perspectives

The Know Sure Thing (KST) oscillator echoes the MACD’s mixed signals, showing mild bullishness on the weekly chart but bearishness on the monthly. Dow Theory analysis further complicates the outlook, with a mildly bearish weekly trend and no clear monthly trend established. These conflicting signals reinforce the notion that Abbott India is navigating a period of technical consolidation, with neither bulls nor bears firmly in control.

Volume and On-Balance Volume (OBV) Insights

Volume-based indicators such as On-Balance Volume (OBV) show no discernible trend on both weekly and monthly timeframes. The lack of volume confirmation suggests that recent price movements may lack strong conviction from market participants, which could limit the sustainability of any short-term rallies.

Long-Term Returns and Relative Performance

Abbott India’s stock has delivered mixed returns relative to the Sensex benchmark over various time horizons. Over the past week and month, the stock has underperformed the Sensex, with returns of -0.55% and -1.93% respectively, compared to the Sensex’s -0.98% and -4.41%. Year-to-date, Abbott India’s decline of -10.06% is less severe than the Sensex’s -13.26%, indicating relative resilience amid broader market weakness.

However, over the one-year period, the stock has lagged the Sensex, falling -17.84% against the benchmark’s -10.34%. This underperformance highlights challenges faced by the company or sector-specific headwinds. On a more positive note, Abbott India has outperformed the Sensex over longer durations, with 3-year returns of 19.89% versus 18.03%, 5-year returns of 62.71% against 42.31%, and an impressive 10-year return of 485.03% compared to the Sensex’s 176.19%. These figures underscore the company’s strong long-term growth trajectory despite recent volatility.

Mojo Score and Rating Revision

MarketsMOJO has revised Abbott India’s Mojo Grade from Hold to Sell as of 12 May 2026, reflecting a deterioration in the stock’s technical and fundamental outlook. The current Mojo Score stands at 42.0, signalling weak momentum and caution for investors. This downgrade aligns with the mixed technical signals and the stock’s recent price underperformance relative to the broader market.

Sector and Industry Context

Operating within the Pharmaceuticals & Biotechnology sector, Abbott India faces sector-specific challenges including regulatory pressures, pricing constraints, and competitive dynamics. The mid-cap classification of the company suggests moderate liquidity and market interest, which can amplify price swings during periods of uncertainty. Investors should weigh these factors alongside technical signals when considering exposure to Abbott India.

Investor Takeaway and Outlook

Abbott India’s current technical profile suggests a cautious stance for investors. The mildly bearish trend, combined with mixed momentum indicators, implies that while short-term rallies may occur, the stock faces significant resistance to sustained upward movement. The absence of strong volume confirmation and neutral RSI readings further temper enthusiasm.

Long-term investors may find comfort in the company’s robust multi-year returns and sector positioning, but near-term volatility and the recent downgrade to a Sell rating warrant prudence. Monitoring key technical levels, such as the 52-week low near ₹25,164 and the moving averages, will be critical to gauge any meaningful trend reversals.

In summary, Abbott India Ltd. remains a stock with a complex technical landscape, where cautious optimism is balanced by persistent bearish undertones. Investors should carefully analyse both technical signals and fundamental developments before making portfolio decisions.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today